CRISPR gene editing promises to revolutionize medical science, and two of its pioneers are getting a prestigious award for their efforts. Emmanuelle Charpentier (shown at left) and Jennifer Doudna (right) have received the 2020 Nobel Prize in Chemistry for their roles in discovering the CRISPR/Cas9 “genetic scissors” used to cut DNA. Charpentier found the key tracrRNA molecule that bacteria use to cut and disable viruses, and collaborated with RNA expert Doudna to eventually ‘reprogram’ the scissors to cut any DNA molecule at a specific point, making the gene editing method viable.

As with some scientific discoveries, there’s some controversy. While the team including Charpentier and Doudna published its work in June 2012, seven months before a Broad Institute-led group released its own findings, it didn’t include certain aspects Broad used when it started patenting gene editing methods in 2014. That led to a patent battle that’s still raging today, with Broad getting “priority” for its patents even as it as denied several motions that could give Charpentier and Doudna an advantage. Broad has already asked to “move beyond litigation” and find a more peaceful settlement.

Source Article